Effect of surface coating on the biodistribution profile of gold nanoparticles in the rat.
暂无分享,去创建一个
Paula Gomes | Tiago Morais | Sónia Fraga | Maria de Lourdes Bastos | Eulália Pereira | José Alberto Duarte | J. Duarte | T. Morais | E. Pereira | M. Bastos | S. Fraga | Maria Elisa Soares | Leonor Soares | Sílvia Maia | Helena Carmo | P. Gomes | H. Carmo | M. Soares | Sílvia Maia | L. Soares
[1] Elodie Boisselier,et al. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. , 2009, Chemical Society reviews.
[2] Dong Liang,et al. Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. , 2009, Biomaterials.
[3] M. Bawendi,et al. Renal clearance of quantum dots , 2007, Nature Biotechnology.
[4] É. Boisselier,et al. Gold Nanoparticles in Nanomedicine: Preparations, Imaging, Diagnosis, Therapies and Toxicity , 2009 .
[5] Takuro Niidome,et al. PEG-modified gold nanorods with a stealth character for in vivo applications. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[6] R. Sperling,et al. Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles , 2010, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[7] E. Giralt,et al. How changes in the sequence of the peptide CLPFFD-NH2 can modify the conjugation and stability of gold nanoparticles and their affinity for beta-amyloid fibrils. , 2008, Bioconjugate chemistry.
[8] S. S. Wang. p-alkoxybenzyl alcohol resin and p-alkoxybenzyloxycarbonylhydrazide resin for solid phase synthesis of protected peptide fragments. , 1973, Journal of the American Chemical Society.
[9] Catherine J. Murphy,et al. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? , 2010, Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology.
[10] G. Fields,et al. Solid Phase Peptide Synthesis Utilizing 9-Fluorenylmethoxycarbonylamino Acids , 1990 .
[11] Keishiro Tomoda,et al. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. , 2008, Colloids and surfaces. B, Biointerfaces.
[12] G. Fields,et al. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. , 2009, International journal of peptide and protein research.
[13] G. Tosi,et al. Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[14] Dakrong Pissuwan,et al. The forthcoming applications of gold nanoparticles in drug and gene delivery systems. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[15] Manuela Semmler-Behnke,et al. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[16] E. Giralt,et al. Homogeneous conjugation of peptides onto gold nanoparticles enhances macrophage response. , 2009, ACS nano.
[17] J. Kimling,et al. Turkevich method for gold nanoparticle synthesis revisited. , 2006, The journal of physical chemistry. B.
[18] Jie Chen,et al. Enhancement of radiation cytotoxicity in breast-cancer cells by localized attachment of gold nanoparticles. , 2008, Small.
[19] Jin Hong,et al. Size-dependent tissue kinetics of PEG-coated gold nanoparticles. , 2010, Toxicology and applied pharmacology.
[20] E. Kaiser,et al. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. , 1970, Analytical biochemistry.
[21] Manuela Semmler-Behnke,et al. Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. , 2010, Biomaterials.
[22] Robert L. Tanguay,et al. In vivo biodistribution and toxicity depends on nanomaterial composition, size, surface functionalisation and route of exposure , 2008 .
[23] Petra Krystek,et al. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. , 2008, Biomaterials.
[24] Hamidreza Ghandehari,et al. Cellular uptake and toxicity of gold nanoparticles in prostate cancer cells: a comparative study of rods and spheres , 2009, Journal of applied toxicology : JAT.
[25] Manuela Semmler-Behnke,et al. Biodistribution of 1.4- and 18-nm gold particles in rats. , 2008, Small.
[26] N. Santos,et al. Probing Surface Properties of Cytochrome c at Au Bionanoconjugates , 2008 .
[27] Irshad Hussain,et al. Rational and combinatorial design of peptide capping ligands for gold nanoparticles. , 2004, Journal of the American Chemical Society.
[28] Mathias Brust,et al. Uptake and intracellular fate of surface-modified gold nanoparticles. , 2008, ACS nano.
[29] Raphaël Lévy. Peptide‐Capped Gold Nanoparticles: Towards Artificial Proteins , 2006, Chembiochem : a European journal of chemical biology.
[30] Bong Hyun Chung,et al. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. , 2009, Toxicology and applied pharmacology.
[31] C. Soto,et al. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. , 2010, Biochemical and biophysical research communications.
[32] Nicholas A Peppas,et al. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.
[33] Håkan Wallin,et al. Protracted elimination of gold nanoparticles from mouse liver. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[34] Division on Earth. Guide for the Care and Use of Laboratory Animals , 1996 .
[35] Y. Hung,et al. Assessment of the In Vivo Toxicity of Gold Nanoparticles , 2009, Nanoscale research letters.
[36] Valery V Tuchin,et al. Circulation and distribution of gold nanoparticles and induced alterations of tissue morphology at intravenous particle delivery , 2009, Journal of biophotonics.
[37] Timo Laaksonen,et al. Stability and electrostatics of mercaptoundecanoic acid-capped gold nanoparticles with varying counterion size. , 2006, Chemphyschem : a European journal of chemical physics and physical chemistry.
[38] Pei-Xun Liu,et al. Toxicologic effects of gold nanoparticles in vivo by different administration routes , 2010, International journal of nanomedicine.
[39] D. Fernig,et al. Determination of size and concentration of gold nanoparticles from UV-vis spectra. , 2007, Analytical chemistry.
[40] Jinatta Jittiwat,et al. Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats. , 2010, Biomaterials.
[41] M Geso,et al. Gold nanoparticles: a new X-ray contrast agent. , 2007, The British journal of radiology.
[42] J. Turkevich,et al. Coagulation of Colloidal Gold , 2002 .
[43] Fernando Albericio,et al. Peptides and metallic nanoparticles for biomedical applications. , 2007, Nanomedicine.
[44] G. Oberdörster,et al. Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.
[45] Manuela Semmler-Behnke,et al. Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration , 2011, Nanotoxicology.
[46] R M Albrecht,et al. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. , 2001, Journal of pharmaceutical sciences.
[47] Fernando Albericio,et al. Improving the brain delivery of gold nanoparticles by conjugation with an amphipathic peptide. , 2010, Nanomedicine.